C9301 HCPCS code: Obecabtagene autoleucel, up to 400 million cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose

C9301 is the HCPCS Level II code for obecabtagene autoleucel, up to 400 million cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose. CMS terminated C9301 on 2025-06-30; do not bill it for later dates of service. Its Medicare coverage code is D (Special coverage instructions apply): May be covered when national or local coverage criteria are met.

Code details

FieldValue
SectionC codes — Outpatient PPS (hospital outpatient temporary codes)
Coverage codeD — Special coverage instructions apply
Pricing indicator53
BETOS categoryO1E — Other drugs
Added2025-04-01
Last action effective2025-07-01
Terminated2025-06-30

What changed for C9301

Frequently asked questions

What is HCPCS code C9301?

C9301 is the HCPCS Level II code for obecabtagene autoleucel, up to 400 million cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose. Short descriptor: "Obecabtagene car pos t".

Does Medicare cover C9301?

Coverage code D — Special coverage instructions apply. May be covered when national or local coverage criteria are met.

Related C93 codes

Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.

Next steps

Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.

All C codes · HCPCS lookup